West to Host Third-Quarter 2025 Conference Call

Rhea-AI Summary

West (NYSE: WST) will release third-quarter 2025 financial results before the market opens on Thursday, October 23, 2025 and will host a conference call the same day at 8:00 a.m. ET.

The event includes a live webcast, a slide presentation posted in the Investors section of the company website on the day of the call, and a replay available for about 90 days. Participants who wish to ask questions must register in advance to receive a dial-in number and unique PIN for question submission.

EXTON, Pa., Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 23, 2025, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

The live webcast can be accessed by clicking here. To ask questions on the conference call, participants need to register in advance by clicking here.  Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the webcast will be available on the Company's website for approximately 90 days after the event.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-third-quarter-2025-conference-call-302578715.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West (WST) report third-quarter 2025 results?

West will release Q3 2025 results before the market opens on October 23, 2025.

What time is the West (WST) Q3 2025 conference call?

The conference call is scheduled for 8:00 a.m. Eastern Time on October 23, 2025.

How can investors listen to West (WST) Q3 2025 webcast?

Investors can access the live webcast via the company's Investor Relations website on the day of the call.

How do I register to ask questions on the West (WST) conference call?

Register in advance through the company's registration link to receive a dial-in number and unique PIN to ask questions.

Will West (WST) provide presentation slides for the Q3 2025 call?

Yes. A slide presentation will be posted in the Investors section of the company website on the day of the call.